Epicure: efficacy of nintedanib as a treatment for epistaxis in HHT disease. A national, randomized, multicenter phase II study

被引：0
|
作者：
Hermann, R. [1 ]
Fargeton, A. [2 ,3 ]
Decullier, E. [4 ]
Chinet, T. [5 ]
Corre, R. [6 ]
Gilbert-Dussardier, B. [7 ]
Grobost, V [8 ]
Hatron, P. [9 ]
Lavigne, C. [10 ]
Leguy-Seguin, V [11 ]
Parrot, A. [12 ]
Riviere, S. [13 ]
Seguier, J. [14 ]
Beaudoin, M. [2 ,3 ]
Roux, A. [4 ]
Bel, F. [15 ]
Gervaise, C. [15 ]
Faure, F. [1 ]
Dupuis-Girod, S. [2 ,3 ]
机构：
[1] Hop Edouard Herriot, HCL, Serv ORL, Lyon, France
[2] Hop Femme Mere Enfant, HCL, Serv Genet, Bron, France
[3] Hop Femme Mere Enfant, HCL, Ctr Reference Malad Rendu Osler, Bron, France
[4] HCL, Unite Rech Clin, Pole Sante Publ, Lyon, France
[5] Hop Ambroise Pare, Serv Radiol & Pneumol Intervent, Boulogne Billancourt, France
[6] Hop Pontchaillou, Serv Pneumol, Rennes, France
[7] Hop J Bernard, Serv Genet, Poitiers, France
[8] CHU Estaing, Serv Med Interne, Clermont Ferrand, France
[9] Hop Jeanne de Flandre, Serv Med Interne, Lille, France
[10] CHU Angers, Serv Med Interne, Angers, France
[11] Hop Bocage, Serv Med Interne, Dijon, France
[12] Hop Tenon, Serv Imagerie & Radiol Intervent, Paris, France
[13] Hop St Eloi, Serv Med Interne, Montpellier, France
[14] Hop La Timone, Serv Med Interne, Marseille, France
[15] Grp Hosp Est, HCL, Pharm, Bron, France
来源：
ANGIOGENESIS | 2019年 / 22卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：629 / 630
页数：2
相关论文
共 50 条
  • [21] Baricitinib in Rheumatoid Arthritis - Interstitial Lung Disease. National Multicenter Study of 72 Patients
    Serrano-Combarro, Ana
    Atienza-Mateo, Belen
    Valero Jaimes, Jesus Alejandro
    Pastor-Mena, Marta
    Melero-Gonzalez, Rafael Benito
    Martin Lopez, Maria
    Castaneda, Santos
    Loarce, Jesus
    Egues Dubuc, Cesar Antonio
    Mena Vazquez, Natalia
    Carrasco-Cubero, Carmen
    Perez-Garcia, Carolina
    Blanco Madrigal, Juan M.
    Vegas Revenga, Nuria
    Perez Albadalejo, Lorena
    Ortega-Castro, Rafaela
    Palma, Desiree
    Fernandez-Ortiz, Ana
    Lopez Lasanta, Maria
    Bufort, Marta Garijo
    Casafont-Sole, Ivette
    Garcia-Valle, Andrea
    Martinez-Vidal, Maria Paz
    Robles, Bryan Josue Flores
    Perez, Evelin Cervantes
    Abascal, Ignacio Brana
    Herrera, Sara Maria Rojas
    Sarmiento-Monroy, Juan Camilo
    Ruiz-Esquide, Virginia
    Riazuelo, Jose Ramon Lamua
    Astigarraga-Urquia, Uxue
    Ferrer, Diego
    Blanco-Alonso, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 959 - 962
  • [22] Upadacitinib and Other JAK Inhibitors in the Treatment of Rheumatoid Arthritis - Interstitial Lung Disease. National Multicenter Study Clinical Practice
    Serrano-Combarro, Ana
    Atienza-Mateo, Belen
    Loarce, Jesus
    Del Olmo Perez, Leticia
    Garcia-Perez, Sara
    Mozo De Rosales, Guillermo Gonzalez
    De Salazar, Jose Rosas-Gomez
    Urruticoechea-Arana, Ana
    Garcia-Valle, Andrea
    Moreno Morales, Juan
    Martin Lopez, Maria
    Lopez Viejo, Patricia
    Ruiz-Esquide, Virginia
    Fernandez Melon, Julia
    Castro-Corredor, David
    Fernandez-Ortiz, Ana
    Melero-Gonzalez, Rafael Benito
    Diez Morrondo, Carolina
    Palma, Desiree
    Del Val Del Amo, Natividad
    Mena Vazquez, Natalia
    Garcia Dorta, Alicia
    Perez Galan, Maria Jose
    Moreno Garcia, Marina Soledad
    Blanco-Alonso, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2795 - 2797
  • [23] A MULTICENTER PHASE II TRIAL ON THE EFFICACY AND SAFETY OF SCLEROTHERAPY USING 3% POLIDOCANOL FOAM TO TREAT SECOND-DEGREE HEMORRHOIDAL DISEASE.
    Gallo, G.
    Sammarco, G.
    Trompetto, M.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 25 - 25
  • [24] Efficacy and safety of bevacizumab on severe bleedings associated with hemorrhagic hereditary telangiectasia: a national, randomized multicenter phase III study
    Dupuis-Girod, S.
    Riviere, S.
    Lavigne, C.
    Fargeton, A. E.
    Gilbert-Dussardier, B.
    Grobost, V
    Leguy-Seguin, V
    Maillard, H.
    Mohamed, S.
    Decullier, E.
    Roux, A.
    Bernard, L.
    Saurin, J. C.
    Saroul, N.
    Faure, F.
    Cartier, C.
    Altwegg, R.
    Laccourreye, L.
    Oberti, F.
    Beaudoin, M.
    Dhelens, C.
    Desvignes, C.
    Azzopardi, N.
    Paintaud, G.
    Hermann, R.
    Chinet, T.
    ANGIOGENESIS, 2023, 26 (01) : S1 - S2
  • [25] SAFETY AND EFFICACY OF TEMOZOLOMIDE TREATMENT WITH NEWLY DIAGNOSED GLIOBLASTOMA IN JAPAN: A MULTICENTER PHASE II CLINICAL STUDY
    Sugiyama, Kazuhiko
    Nishikawa, Ryo
    Takeshima, Hideo
    Nakamura, Hideo
    Aoki, Tomokazu
    Takahashi, Jun
    Takahash, Hideaki
    Saito, Akihiko
    Sawamura, Yutaka
    Kurisu, Kaoru
    Matsutani, Masao
    NEURO-ONCOLOGY, 2009, 11 (06) : 948 - 948
  • [26] Nintedanib plus pemetrexed/cisplatin followed by maintenance nintedanib for mareseetable malignant pleural mesothelionta (MPM): An international, multicenter, randomized, double-blind, placebo-controlled phase II study.
    Scagliotti, Giorgio V.
    Leighi, Natasha B.
    Nowak, Anna K.
    Paviakis, Nick
    Popat, Sanjay
    Sorensen, Jens Bonn
    Barrueco, Jose
    Kaiser, Rolf
    Loembe, Arsene-Blenvenu
    Mueller, Martha
    von Wangenheim, Ute
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Randomized phase II trial comparing the efficacy and safety of nintedanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Palmer, Daniel H.
    Ma, Yuk Ting
    Peck-Radosavljevic, Markus
    Ross, Paul J.
    Graham, Janet Shirley
    Fartoux, Laetitia
    Deptala, Andrzej
    Wenz, Arne
    Hocke, Julia
    Loembe, Arsene-Bienvenu
    Meyer, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [28] Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
    Gonzalez Quero, Beatriz
    Tabernero Huguet, Eva
    Altube, Lander
    Ugedo, Javier
    Leal, Victoria
    Solorzano Santobena, Jone
    Martinez Indart, Lorea
    Garcia Fuertes, Julia
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Fumagalli, Luca
    Bratta, Massimo
    Rea, Silvio
    ANTI-CANCER DRUGS, 2008, 19 (02) : 201 - 207
  • [30] A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World
    Lopez, Liliana
    Alvarez, Fiorela
    Ramos, Ana Pilar
    Llanos-Cuentas, Alejandro
    Echevarria, Juan
    Velez, Ivan
    Boni, Marina
    Rode, Joelle
    Quintero, Juliana
    Jimenez, Alejandra
    Tabares, Yulied
    Mendez, Claudia
    Arana, Byron
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (03):
12345